Nureca Ltd - 543264 - Clarification On Price Movement
Please find enclosed reply letter on "Clarification of Price Movement"10-05-2021
10-05-2021
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release titled: "Healthcare leader Dr Trust Announces New Addition to Senior Leadership Team"10-05-2021
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release titled: "Healthcare leader Dr Trust Announces New Addition to Senior Leadership Team"10-05-2021
Nureca Ltd - 543264 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayNureca Ltd 2CINU24304MH2016PLC320868 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.93 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: GURVIKRAM SINGH Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Sakshi Mittal Designation: Chief Financial Officer EmailId: [email protected] Date: 29/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.29-04-2021
Nureca Ltd - 543264 - Shareholding for the Period Ended March 31, 2021
Nureca Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here20-04-2021
Nureca Ltd - 543264 - Compliance Certificate Under Regulation 7 (3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
Pursuant to regulation 7(3) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the compliance certificate for the half year ended on March 31, 2021.19-04-2021
Nureca hits 10% upper circuit for second straight day; zooms 83% in 3 weeks
The company said the movement in volume / price of equity shares of the company is purely market-driven19-04-2021
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of Securities LODR Regulations, we wish to inform you that the Board of Directors have approved to appoint Dr. Shrikant Uttam Tamhane (DIN-08965471) on the Board as an Additional Director (Independent) of the company from April 15, 2021 till the date of forthcoming Annual General Meeting in which he can be appointed as a regular Independent Director. The Detailed letter is attached herewith15-04-2021
Nureca Ltd - 543264 - Clarification On Price Movement
Enclosed is Company'' reply letter,13-04-2021
Nureca Ltd - 543264 - Clarification sought from Nureca Ltd
The Exchange has sought clarification from Nureca Ltd on April 13, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.13-04-2021